PubMed

Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results.

Arias L, Planas N, Prades S, Caminal JM, Rubio M, Pujol O, Roca G.

Br J Ophthalmol. 2008 Aug;92(8):1035-9. Review.PMID: 18653595 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

Chan WM, Lai TY, Liu DT, Lam DS.

Ophthalmology. 2007 Dec;114(12):2190-6. Epub 2007 Jun 28.PMID: 17599414 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.

Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB.

Am J Ophthalmol. 2009 Jan;147(1):84-93.e1. Epub 2008 Sep 6.PMID: 18774547 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.

Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS.

Br J Ophthalmol. 2007 Feb;91(2):157-60. Epub 2006 Jul 26.PMID: 16870653 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.

Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, Oshima Y, Kusaka S, Tano Y.

Br J Ophthalmol. 2007 Feb;91(2):161-5. Epub 2006 Aug 16.PMID: 16914470 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia.

Rhéaume MA, Sebag M.

Can J Ophthalmol. 2008 Oct;43(5):576-80.PMID: 18982035 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.

Chan WM, Lai TY, Liu DT, Lam DS.

Am J Ophthalmol. 2007 Jun;143(6):977-983. Epub 2007 Apr 24.PMID: 17459318 [PubMed - indexed for MEDLINE]Related articles

Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia.

Hernández-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, Fromow-Guerra J, Amaya-Espinosa A, Solís-Vivanco A, Reyna-Castelán E, Abraham-Marín M, Martínez-Castellanos MA, Aiello LP.

Retina. 2007 Jul-Aug;27(6):707-12.PMID: 17621179 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization.

Mandal S, Venkatesh P, Sampangi R, Garg S.

Eur J Ophthalmol. 2007 Jul-Aug;17(4):620-6.PMID: 17671940 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.

Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S.

Br J Ophthalmol. 2009 Apr;93(4):448-51. Epub 2008 Dec 17.PMID: 19091851 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study.

Chan WM, Lai TY, Liu DT, Lam DS.

Br J Ophthalmol. 2009 Feb;93(2):150-4. Epub 2008 Sep 18.PMID: 18801766 [PubMed - indexed for MEDLINE]Related articles

Treatment of choroidal neovascularization using intravitreal bevacizumab.

Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

Spaide RF, Laud K, Fine HF, Klancnik JM Jr, Meyerle CB, Yannuzzi LA, Sorenson J, Slakter J, Fisher YL, Cooney MJ.

Retina. 2006 Apr;26(4):383-90.PMID: 16603955 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.

Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, Tano Y.

Am J Ophthalmol. 2009 Jan;147(1):94-100.e1. Epub 2008 Sep 6.PMID: 18774550 [PubMed - indexed for MEDLINE]Related articles

Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization.

Konstantinidis L, Mantel I, Pournaras JA, Zografos L, Ambresin A.

Graefes Arch Clin Exp Ophthalmol. 2009 Mar;247(3):311-8. Epub 2008 Nov 29.PMID: 19043731 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population.

Azad RV, Khan MA, Chanana B, Azad S.

Jpn J Ophthalmol. 2008 Jan-Feb;52(1):52-6. Epub 2008 Mar 28.PMID: 18369701 [PubMed - indexed for MEDLINE]Related articles

A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.

Algvere PV, Steén B, Seregard S, Kvanta A.

Acta Ophthalmol. 2008 Aug;86(5):482-9. Epub 2007 Dec 14.PMID: 18162062 [PubMed - indexed for MEDLINE]Related articles